Back to directory

Center for rare neuromuscular diseases

Policlinico Umberto I of Rome-Sapienza University of Rome

ATTRv ATTRwt 2 Rare Subtypes

Contact Information

Primary Contact

Marco Ceccanti

Dr/PhD

Activity level

  • Patients per year150
  • New diagnoses per year30

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyOn-site
  • PathologyOn-site
Other specialists
GastroenterologyHepatologyPulmonologyRheumatologyOrthopaedicsGeneticistsGenetic counsellorsNuclear medicine specialistsCardiac imaging specialistsRadiologistsTransplant programme - heartTransplant programme - kidneyTransplant programme - liverAllied health professionals (NP, PA)Palliative care

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)On-site
  • Amyloid typingOn-site
  • Genetic testingThrough network partners
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site
Partner laboratories

Genoma and RI Genetics for genetic testings

Subtype expertise

  • ALNo
  • ATTRvYes
  • ATTRwtYes
  • AANo
Rare subtypes
Localised amyloidosisBeta 2 microglobulin (Aβ2M)

Treatment options

  • Chemotherapy (AL)Available on-site
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable on-site
  • Heart transplantAvailable on-site
  • Kidney transplantAvailable on-site
  • Liver transplantAvailable on-site

Patient support services

Services offered
Genetic counsellingNutritional guidance (dietitian)

Networks & telemedicine

  • Telemedicine / virtual consultationNo
  • Part of a formal amyloidosis networkYes
  • Diagnostic services for other organisationsYes

Last confirmed: 27 March 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.